- Home
- RCEL vs RSSS Comparison
RCEL vs RSSS Comparison
Compare RCEL & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- RSSS
- Stock Information
- Founded
- RCEL N/A
- RSSS 2006
- Country
- RCEL United States
- RSSS United States
- Employees
- RCEL N/A
- RSSS N/A
- Industry
- RCEL Medical/Dental Instruments
- RSSS Business Services
- Sector
- RCEL Health Care
- RSSS Consumer Discretionary
- Exchange
- RCEL Nasdaq
- RSSS Nasdaq
- Market Cap
- RCEL 107.8M
- RSSS 110.0M
- IPO Year
- RCEL N/A
- RSSS N/A
- Fundamental
- Price
- RCEL $3.42
- RSSS $3.06
- Analyst Decision
- RCEL Buy
- RSSS Strong Buy
- Analyst Count
- RCEL 5
- RSSS 1
- Target Price
- RCEL $11.80
- RSSS $5.00
- AVG Volume (30 Days)
- RCEL 260.2K
- RSSS 57.6K
- Earning Date
- RCEL 11-06-2025
- RSSS 11-13-2025
- Dividend Yield
- RCEL N/A
- RSSS N/A
- EPS Growth
- RCEL N/A
- RSSS N/A
- EPS
- RCEL N/A
- RSSS 0.04
- Revenue
- RCEL $74,884,000.00
- RSSS $49,057,981.00
- Revenue This Year
- RCEL $20.40
- RSSS $5.79
- Revenue Next Year
- RCEL $32.94
- RSSS $8.46
- P/E Ratio
- RCEL N/A
- RSSS $76.75
- Revenue Growth
- RCEL 38.32
- RSSS 9.94
- 52 Week Low
- RCEL $3.37
- RSSS $2.32
- 52 Week High
- RCEL $14.16
- RSSS $4.24
- Technical
- Relative Strength Index (RSI)
- RCEL 28.06
- RSSS 36.46
- Support Level
- RCEL $3.88
- RSSS $3.21
- Resistance Level
- RCEL $3.91
- RSSS $3.30
- Average True Range (ATR)
- RCEL 0.23
- RSSS 0.14
- MACD
- RCEL -0.05
- RSSS -0.02
- Stochastic Oscillator
- RCEL 0.00
- RSSS 9.44
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.